MedGenesis Therapeutix Inc. MedGenesis Therapeutix Inc.
 

Company

News ] [ Our People ] [ Awards ]

Our People

[Management Team ] [ Scientific Advisors ] [ Board of Directors ]

Scientific Advisors

CED Advisory Committee

Krystof Bankiewicz, M.D., Ph.D.
Dr. Bankiewicz is a Professor of Neurological Surgery at the University of California, San Francisco and a leader in the area of restorative interventions, specifically drug delivery and gene transfer, in models of Parkinson's Disease and brain tumors.

Steven Gill, M.D.
Dr. Gill is Professor of Neurosurgery at the University of Bristol, UK. He was the principal investigator on the first clinical trial testing intraputaminal GDNF in Parkinson's patients, and is the most experienced clinical user of GDNF worldwide. In addition, he has been Renishaw's key scientific advisor on the development of the neuro|convectģ catheter system.

Sandeep Kunwar, M.D.
Dr. Kunwar is Associate Professor of Neurosurgery at the University of California, San Francisco, a Principal Investigator in the Brain Tumor Research Center and Co-Director of the UCSF Pituitary Treatment Center. He is a clinical neurosurgeon and a world leader in the application of Convection Enhanced Delivery to patient care and has served as the lead principal investigator for a number of international multi-institutional CED clinical trials.

Parkinson's Advisory Committee

Howard J. Federoff, M.D., Ph.D.
Dr. Federoff is Executive Dean, Georgetown University School of Medicine as well as Executive Vice President, Georgetown University Medical Center. Dr. Federoff formed and leads the US national consortium "The Parkinson's Disease Gene Therapy Study Group" whose mission is to establish a rigorous basis for moving novel gene therapeutics from preclinical studies to clinical trials.

Michael Aminoff, M.D.
Dr. Aminoff is a Professor of Neurology and Executive Vice-Chair of the Department of Neurology at the University of California, San Francisco. He is also the Director of the Parkinsonís Disease and Movement Disorders Clinic at the University of California Medical Center. Dr. Aminoff has published extensively in neurology, Parkinson's disease and electrophysiology including authoring more than 200 papers, 27 books, 65 book chapters, and editing the Handbook of Clinical Neurology series.

Roger Kurlan, M.D.
Dr. Kurlan, is the Director of the Movement Disorders Program at Overlook Hospital. He was a founding member of the Parkinson Study Group and has more than 200 publications in the field of movement disorders, encompassing clinical phenomenology, nosology, epidemiology, genetics, etiology and particularly experimental therapeutics which is his main research focus.

Anthony E. Lang, M.D.
Dr. Lang is a world renowned clinician and researcher in Parkinsonís disease and movement disorders. He is a Professor of Neurology at the University of Toronto, Director of the Morton and Gloria Schulman Parkinson's Disease Clinic and Director of the National Parkinson Foundation Centre of Excellence at the University of Toronto. He also holds the Jack Clark Chair for Parkinsonís Disease Research at the University of Toronto. Dr. Lang has published extensively in the field of Parkinson's disease and movement disorders producing more than 500 publications as well as numerous books, book chapters, letters and editorials.

A. Jon Stoessl, M.D.
Dr. Stoessl is a Professor of Medicine and Acting Head of the Division of Neurology at the University of British Columbia. He is the Director of the Pacific Parkinson's Research Centre and National Parkinson Foundation Centre of Excellence at the University of British Columbia. He received the Order of Canada for his contributions to research in health care. He has published extensively in the field of Parkinsonís disease and has particular research interests in positron emission tomography (PET), biomarkers and placebo response.

Additional Scientific Advisors

Michael A. Rogawski, M.D., Ph.D. - Scientific Advisor - Epilepsy
Dr. Rogawski is professor and chair of the Department of Neurology at the University of California, Davis where he leads a multidisciplinary research team focused on therapeutic strategies for epilepsy.

Ashokk K. Shetty, Ph.D. - Scientific Advisor - Epilepsy
Dr. Shetty is a professor in the Division of Neurosurgery at Duke University Medical Center and has conducted ground-breaking research on the pathophysiology and neurobiology of chronic epilepsy with a particular focus on hippocampal neurogenesis and plasticity and the potential of cell transplantation therapy.

Josef Miller, Ph.D. - Scientific Advisor - SNHL
Dr. Miller is the Ruth & Lynn Townsend Professor of Communication Disorders and Director of the Cochlear Signaling and Tissue Engineering Laboratory at the Kresge Hearing Research Institute, Department of Otolaryngology, University of Michigan. Additionally, he is a Professor at the Karolinska Institute in Stockholm, Sweden. Dr. Millerís research is focused on mechanisms of protection and repair of the traumatized cochlea, translating into preventive and regenerative therapies for hearing loss and acquired deafness.

 

 

© MedGenesis Therapeutix Inc.